PHARMACOLOGICAL RESPONSE DATA FOR COMPARATIVE BIOAVAILABILITY STUDIES OF CHLORPROMAZINE ORAL DOSAGE FORMS IN HUMANS .1. PUPILLOMETRY

被引:11
作者
SMOLEN, VF
MURDOCK, HR
STOLTMAN, WP
CLEVENGER, JW
COMBS, LW
WILLIAMS, EJ
机构
[1] PURDUE UNIV,SCH PHARM & PHARM SCI,INTERDISCIPLINARY DRUG ENGN & ASSESSMENT LAB,W LAFAYETTE,IN 47907
[2] PURDUE UNIV,DEPT IND & PHYS PHARM,W LAFAYETTE,IN 47907
[3] USDA,DIV BIOPHARM,BUR DRUGS,ROCKVILLE,MD 20852
关键词
D O I
10.1002/j.1552-4604.1975.tb02338.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:734 / 751
页数:18
相关论文
共 22 条
[1]   DESTRUCTION OF CHLORPROMAZINE DURING ABSORPTION IN RAT IN-VIVO AND IN-VITRO [J].
CURRY, SH ;
DMELLO, A ;
MOULD, GP .
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 42 (03) :403-&
[2]   PLASMA LEVELS OF CHLORPROMAZINE AND SOME OF ITS RELATIVELY NON-POLAR METABOLITES IN PSYCHIATRIC PATIENTS [J].
CURRY, SH ;
MARSHALL, JH .
LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1968, 7 (1P1) :9-&
[3]  
CURRY SH, 1973, BIOLOGICAL EFFECTS D, P201
[4]   CHLORPROMAZINE IN THE CONTROL OF VOMITING IN CHILDREN - PRELIMINARY CLINICAL EVALUATION [J].
DAESCHNER, CW ;
CLARK, JL ;
GEORGE, GY ;
FRANKEL, RA .
AMA AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1955, 89 (05) :525-530
[5]  
FINK S, 1955, GASTROENTEROLOGY, V28, P731
[6]  
HOLLISTER LE, 1970, CLIN PHARMACOL THER, V11, P49
[7]  
KUEHN PB, IN PRESS
[9]  
MEYER JH, 1954, AM J MED SCI, V228, P174
[10]  
SAKALIS G, 1972, CLIN PHARMACOL THER, V13, P931